Updated National and State-Specific Prevalence of Congenital Cytomegalovirus Infection, United States, 2018-2022
- PMID: 39231390
- PMCID: PMC12068531
- DOI: 10.1097/PHH.0000000000002043
Updated National and State-Specific Prevalence of Congenital Cytomegalovirus Infection, United States, 2018-2022
Abstract
Context: Congenital cytomegalovirus (cCMV) infection is the most common infectious cause of birth defects and the leading non-genetic cause of sensorineural hearing loss in the United States. Prior national cCMV infection prevalence estimates were based on one multi-site screening study conducted between 2007 and 2012 and were not adjusted for sociodemographic characteristics, such as maternal race and ethnicity or age.
Objective: This study sought to estimate national and state-specific prevalence of cCMV infection in the United States, adjusted for maternal race and ethnicity and maternal age group, by pooling estimates from published studies.
Design: We searched PubMed for U.S. cCMV newborn screening studies conducted between 2003 and 2023. From included studies, we abstracted maternal race and ethnicity- and age group-stratified cCMV prevalence to estimate strata-specific pooled prevalence. We obtained strata-specific weights from live birth data.
Main outcome measure: Estimated adjusted national and state-specific prevalence estimates from 2018 to 2022.
Results: Four studies (conducted 2004-2005, 2008, 2007-2012, and 2016-2021) were included for data abstraction. Overall, infants born to non-Hispanic Black (9.3 [8.2-10.5] per 1000) or non-Hispanic American Indian and Alaska Native (8.5 [2.1-33.2] per 1000) mothers had the highest cCMV prevalence. The estimated race and ethnicity-adjusted prevalence was 4.6-4.7 per 1000 live births nationally and ranged from 3.9 to 6.5 per 1000 across states from 2018 to 2022. Southern states and Alaska consistently had the highest cCMV prevalence. The estimated maternal age group-adjusted prevalence was 4.3-4.4 per 1000 live births nationally and ranged from 3.8 to 5.1 per 1000 across states from 2018 to 2022.
Conclusions: States with larger proportions of racial and ethnic minorities had higher estimated prevalence of cCMV infection compared to states with larger proportions of White persons. These estimates may be useful for informing cCMV surveillance at the jurisdiction level and developing tailored, culturally relevant education and prevention strategies for persons at higher risk.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Racial and Ethnic Differences in the Prevalence of Congenital Cytomegalovirus Infection.J Pediatr. 2018 Sep;200:196-201.e1. doi: 10.1016/j.jpeds.2018.04.043. Epub 2018 May 18. J Pediatr. 2018. PMID: 29784513
-
Association Between Congenital Cytomegalovirus and the Prevalence at Birth of Microcephaly in the United States.JAMA Pediatr. 2020 Dec 1;174(12):1159-1167. doi: 10.1001/jamapediatrics.2020.3009. JAMA Pediatr. 2020. PMID: 32926077 Free PMC article.
-
Congenital Cytomegalovirus Infection Burden and Epidemiologic Risk Factors in Countries With Universal Screening: A Systematic Review and Meta-analysis.JAMA Netw Open. 2021 Aug 2;4(8):e2120736. doi: 10.1001/jamanetworkopen.2021.20736. JAMA Netw Open. 2021. PMID: 34424308 Free PMC article.
-
Epidemiology and Economic Burden of Diagnosed Congenital Cytomegalovirus Infection in the First 2 Years of Life among Commercially Insured and Medicaid-Insured Individuals in the United States.Clin Ther. 2025 Jun;47(6):426-435. doi: 10.1016/j.clinthera.2025.03.006. Epub 2025 Apr 9. Clin Ther. 2025. PMID: 40204615
-
Congenital Cytomegalovirus Infection.J Infect Dis. 2020 Mar 5;221(Suppl 1):S9-S14. doi: 10.1093/infdis/jiz446. J Infect Dis. 2020. PMID: 32134480 Free PMC article. Review.
Cited by
-
Human cytomegalovirus gH/gL/gO binding to PDGFRα provides a regulatory signal activating the fusion protein gB that can be blocked by neutralizing antibodies.J Virol. 2025 May 20;99(5):e0003525. doi: 10.1128/jvi.00035-25. Epub 2025 Apr 9. J Virol. 2025. PMID: 40202318 Free PMC article.
-
Human cytomegalovirus gH/gL/gO binding to PDGFRα provides a regulatory signal activating the fusion protein gB that can be blocked by neutralizing antibodies.bioRxiv [Preprint]. 2025 Jan 8:2025.01.08.631902. doi: 10.1101/2025.01.08.631902. bioRxiv. 2025. Update in: J Virol. 2025 May 20;99(5):e0003525. doi: 10.1128/jvi.00035-25. PMID: 39829861 Free PMC article. Updated. Preprint.
-
Congenital Cytomegalovirus (cCMV) Infection as a Leading Cause of Pediatric Hearing Loss: Review.Children (Basel). 2025 May 8;12(5):613. doi: 10.3390/children12050613. Children (Basel). 2025. PMID: 40426792 Free PMC article. Review.
References
-
- Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007; 17(5): 355–63. - PubMed
-
- Morton CC, Nance WE. Newborn hearing screening--a silent revolution. N Engl J Med 2006; 354(20): 2151–64. - PubMed
-
- Fowler KB, Ross SA, Shimamura M, et al. Racial and Ethnic Differences in the Prevalence of Congenital Cytomegalovirus Infection. J Pediatr 2018; 200: 196–201 e1. - PubMed